CVS is now covering long-acting injectable PrEP, representing a shift from last year when the pharmacy giant announced it was ...

FAYETTEVILE, N.C. (WTVD) -- Fayetteville native John Rowell calls the FDA's approval of the first injectable treatment for HIV pre-exposure prevention, PrEP, "monumental." The FDA said the injectable ...

Lenacapavir, a long-acting injectable PrEP, requires two injections annually, marking a significant advancement in HIV ...

Kenya will this year begin rolling out a new long-acting injectable HIV prevention drug, Lenacapavir, positioning the country ...

At least 1.4 million Kenyans are living with HIV, with approximately 21,009 people estimated to have died from AIDS-related ...

The U.S. Food and Drug Administration (FDA) recently approved a groundbreaking new option for preventing HIV, the virus that causes AIDS. The injectable drug lenacapavir was approved in June and is ...

The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir (Yeztugo) for HIV pre-exposure prophylaxis (PrEP), but will that ensure the ...

Duale stated that the recommendation, made through the Pharmacy and Poisons Board, covers Lenacapavir 300 mg tablets and Lenacapavir 464 mg injectable solution. - Kenya breaking news | Kenya news ...

The first ever injectable drug that can prevent HIV has been approved for use in England and Wales. Subscribe to our newsletter for the latest sci-tech news updates. The drug, cabotegravir, would ...

The government plans to introduce lenacapavir, a long-acting injectable drug for HIV prevention, in the last quarter of the ...

Dr Robert Mutumba, the head of the Aids Control Programme at the Ministry of Health, told Daily Monitor that Ugandans are ...

For 27 years, Esther Shiyayo and her husband have navigated life in a discordant marriage. Esther is HIV‑positive while he remains HIV‑negative. To maintain his status, he faithfully took a daily dose ...